Skip to content
Governance Register

← US public companies

Adamas Pharmaceuticals Inc

SEC CIK 1328143 · ADMS · last insider filing 2021-11-24

Directors (from insider filings)

NameCapacity as filedFilings
Demski Martha J Director filed 2014 - 2021
Richo Anna Director filed 2020 - 2021
Bigham Michael Director filed 2016 - 2021
Mahoney David L Director filed 2014 - 2021
Macphee John A Director filed 2014 - 2021
Ericson William W. Director filed 2014 - 2021
Mcfarlane Neil F. Director · Chief Executive Officer filed 2019 - 2021
Papapetropoulos Spyros Director filed 2020 - 2021
Dier Mardi Director filed 2017 - 2021
Lieberburg Ivan M Director filed 2014 - 2020
Went Gregory T Director · Chief Executive Officer filed 2014 - 2019
Booth Richard H Director filed 2014 - 2017
Lewis Sara Grootwassink Director filed 2014 - 2015

Officers (from insider filings)

NameTitle as filedFilings
Prentiss Christopher B Chief Financial Officer filed 2017 - 2021
Shreedhar Vijay Chief Commercial Officer filed 2019 - 2021
Merriweather Alfred G Chief Financial Officer filed 2017 - 2019
Rhodes Jennifer J General Counsel filed 2016 - 2019
Patni Rajiv Chief Medical Officer filed 2015 - 2019
King Richard Chief Operating Officer filed 2017 - 2018
Dawson William J Chief Financial Officer filed 2014 - 2017
Mcclure Natalie SVP, Product Development filed 2014 - 2016
Knapp Jeffrey H Chief Operating Officer filed 2014 - 2015
Shin Grace General Counsel filed 2014 - 2014
Coffee Michael Denis Senior VP, Strategy & Planning filed 2014 - 2014
Rimac Anthony M Chief Financial Officer filed 2014 - 2014

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.